Health Trials

Acute Respiratory Viral Infection

2

Review clinical trials related to Acute Respiratory Viral Infection. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years

Multicenter double-blind placebo-controlled randomized in parallel groups clinical trial.

Participants needed: 374
Trial details
Phase: Phase 3Age: 3-12Biological sex: AllType: InterventionalSponsor: Materia Medica HoldingUpdated: Mar 13, 2026Locations: 35
Eligibility criteria

Children of either gender aged 3 to12 years . [+3]

Clinical symptoms of severe influenza/ARVI requiring hospitalization. [+14]

Read more
Status: Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.

The objective of this study is to investigate the efficacy, safety, and tolerability of investigational product Ingavirin forte capsules (Valenta Pharm JSC) administered at different doses compared with medicinal product Ingavirin, 90 mg, capsules (Valenta Pharm JSC) in subjects with influenza or other acute respiratory viral infections (ARVIs).

Participants needed: 300
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Valenta Pharm JSCUpdated: Feb 19, 2026Locations: 11
Eligibility criteria

Voluntarily and personally signed Informed Consent Form (ICF) by a participant o... [+9]

Clinically significant allergic history; [+35]

Read more